Our technology platform consists of an automated hardware system for producing, dosing and injecting 15O-water and analytical software for processing the scan images
IMPORTANT NOTICE: MedTrace’s products are not currently cleared for routine use in any markets, including both the US and Europe. In the US, 15O-water is currently under investigation as an investigational drug in a Phase 3 clinical trial. In Europe, its use is in compliance with approvals granted by national drug authorities, in accordance with the specific legislation of each member state.
Accuracy
Efficiency
Single scans can generally be completed in about 4 minutes1